PT1283043E - Solução oftálmica - Google Patents

Solução oftálmica Download PDF

Info

Publication number
PT1283043E
PT1283043E PT01932088T PT01932088T PT1283043E PT 1283043 E PT1283043 E PT 1283043E PT 01932088 T PT01932088 T PT 01932088T PT 01932088 T PT01932088 T PT 01932088T PT 1283043 E PT1283043 E PT 1283043E
Authority
PT
Portugal
Prior art keywords
ophthalmic solution
pericorneal
vasoconstrictor
conjunctiva
ameliorating
Prior art date
Application number
PT01932088T
Other languages
English (en)
Inventor
Hisayuki Nakayama
Shuichi Nishihata
Hiroshi Aki
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of PT1283043E publication Critical patent/PT1283043E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT01932088T 2000-05-17 2001-05-16 Solução oftálmica PT1283043E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000145641 2000-05-17

Publications (1)

Publication Number Publication Date
PT1283043E true PT1283043E (pt) 2008-02-07

Family

ID=18652119

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01932088T PT1283043E (pt) 2000-05-17 2001-05-16 Solução oftálmica

Country Status (10)

Country Link
EP (1) EP1283043B1 (pt)
JP (2) JP4737911B2 (pt)
KR (1) KR100776577B1 (pt)
CN (1) CN1270707C (pt)
AT (1) ATE383147T1 (pt)
AU (1) AU2001258755A1 (pt)
DE (1) DE60132325T2 (pt)
ES (1) ES2295161T3 (pt)
PT (1) PT1283043E (pt)
WO (1) WO2001087304A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5456234B2 (ja) 2003-06-30 2014-03-26 アルザ・コーポレーシヨン 非揮発性の対イオンを含有する被覆された微小突起のための製剤
JP4961671B2 (ja) * 2004-02-27 2012-06-27 大正製薬株式会社 点眼剤
JP2005239681A (ja) * 2004-02-27 2005-09-08 Taisho Pharmaceut Co Ltd 眼科用剤
JP5434981B2 (ja) * 2004-02-27 2014-03-05 大正製薬株式会社 点眼剤
JP2005247802A (ja) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd 点眼剤
JP4919666B2 (ja) * 2005-01-26 2012-04-18 ロート製薬株式会社 プラノプロフェン含有組成物
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
WO2008026756A1 (en) * 2006-08-28 2008-03-06 Senju Pharmaceutical Co., Ltd. Ophthalmic percutaneous absorption type preparation
WO2009074853A2 (en) * 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
CN114099505B (zh) * 2021-12-07 2023-10-27 湖北远大天天明制药有限公司 一种眼用组合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
JP2824863B2 (ja) * 1989-07-12 1998-11-18 エーザイ株式会社 α▲下１▼―ブロッカー点眼剤
JPH04327533A (ja) * 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
EP0719156A1 (en) * 1993-09-07 1996-07-03 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
JP4737911B2 (ja) 2011-08-03
AU2001258755A1 (en) 2001-11-26
KR20030001490A (ko) 2003-01-06
EP1283043B1 (en) 2008-01-09
ES2295161T3 (es) 2008-04-16
JP2011093923A (ja) 2011-05-12
EP1283043A4 (en) 2003-07-02
CN1438886A (zh) 2003-08-27
CN1270707C (zh) 2006-08-23
DE60132325D1 (de) 2008-02-21
EP1283043A1 (en) 2003-02-12
WO2001087304A1 (fr) 2001-11-22
KR100776577B1 (ko) 2007-11-16
DE60132325T2 (de) 2009-01-02
ATE383147T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
USD419887S (en) Bottle
EP1283043A4 (en) OPHTHALMIC SOLUTION
BR0216099B1 (pt) "conjunto de desgaste".
NO995946D0 (no) Formede oftalmiske linser
MY134110A (en) Combinations of reboxetine and neuroleptic agents
SE9900100D0 (sv) New compounds
MXPA03004041A (es) Lentes oftalmicas sin union y metodos para su produccion.
NO20010556D0 (no) Fremgangsmåte for oftalmisk administrering
EP1764092A3 (en) Selecting compounds for treatment of Alzheimer's disease
HK1068962A1 (en) Multifocal ophthalmic lenses
BR0211935A (pt) Métodos para o desenho de lentes oftálmicas multifocais
MXPA04005784A (es) 2-fenilbenzofuranos sustituidos como agentes estrogenitos.
USD479090S1 (en) Pitcher
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
WO2002053519A3 (en) Hydrophobic polyamine analogs and methods for their use
EP1515722A4 (en) OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
AU2002232437A1 (en) Ophthalmic lubricating solution adapted for use in lasik surgery
RS51003B (sr) Derivat piridin-1-oksida i postupak za njegovu transformaciju u farmaceutski efikasna jedinjenja
EP1581503A4 (en) OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
ITRM20010438A0 (it) Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
EP1515721A4 (en) OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
WO2002043757A3 (de) Arzneimittel zur vermeidung oder behandlung von durch humanen papillomavirus-typ 18-hervorgerufenem tumor
USD522875S1 (en) Bottle
CA2414586A1 (en) Agent for therapeutic treatment of optic nerve diseases and the like